The Center to STOP-COVID

CATALYST Executive Director Ann Scheck McAlearney will serve as a co-principal investigator for the Center to STOP-COVID, a new Serological Sciences Center of Excellence supported by a five-year, $10 million grant from the National Cancer Institute in the National Institutes of Health. The effort will study the long-term effect of COVID-19 on first responders, health care workers and the general population. For more information about the center, visit the links below.

Ohio State to study COVID-19 in first responders with $10 million grant

Columbus Dispatch: Ohio State receives $10 million grant to study impact of COVID-19 on first responders

NIH to launch the Serological Sciences Network for COVID-19, announce grant and contract awardees

New lab test clarifies the potential protective effects of COVID-19 antibodies

Nature Biotechnology: COVID-19 antibodies on trial